Buy all financials of Fresenius Medical Care
from $199 /monthBuy annual subscriptions for all our products.
summary | Unit |
1996 | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 |
Sales | EUR mil |
Gross Profit | EUR mil |
EBIT | EUR mil |
Net Profit | EUR mil |
ROE | % |
EBIT Margin | % |
Net Margin | % |
Employees |
... | ... | ... | 10,739 | 11,003 | 11,937 | 15,089 | 16,191 | |||||||||||||||
... | ... | ... | 3,581 | 3,569 | 3,767 | 4,806 | 5,225 | |||||||||||||||
... | ... | ... | 1,704 | 1,674 | 1,702 | 2,122 | 2,323 | |||||||||||||||
... | ... | ... | 924 | 836 | 788 | 928 | 1,124 | |||||||||||||||
... | ... | ... | 13.3% | 11.4% | 9.66% | 9.48% | 9.93% | |||||||||||||||
... | ... | ... | 15.9% | 15.2% | 14.3% | 14.1% | 14.4% | |||||||||||||||
... | ... | ... | 8.60% | 7.60% | 6.60% | 6.15% | 6.94% | |||||||||||||||
86,153 | 90,690 | 99,895 | 104,033 | 109,319 |
Total Assets | EUR mil |
Non-Current Assets | EUR mil |
Current Assets | EUR mil |
Shareholders' Equity | EUR mil |
Liabilities | EUR mil |
Non-Current Liabilities | EUR mil |
Current Liabilities | EUR mil |
Net Debt/EBITDA | |
Net Debt/Equity | |
Cost of Financing | % |
... | ... | ... | 16,918 | 16,767 | 20,976 | 23,344 | 25,537 | |||||||||||||||
... | ... | ... | 12,274 | 12,208 | 15,424 | 17,115 | 18,602 | |||||||||||||||
... | ... | ... | 4,643 | 4,559 | 5,552 | 6,229 | 6,935 | |||||||||||||||
... | ... | ... | 7,373 | 7,349 | 8,969 | 10,606 | 12,040 | |||||||||||||||
... | ... | ... | 9,544 | 9,418 | 12,007 | 12,738 | 13,498 | |||||||||||||||
... | ... | ... | 7,142 | 6,841 | 9,133 | 8,919 | 8,721 | |||||||||||||||
... | ... | ... | 2,402 | 2,577 | 2,874 | 3,819 | 4,776 | |||||||||||||||
... | ... | ... | 2.65 | 2.59 | 3.27 | 2.69 | 2.45 | |||||||||||||||
... | ... | ... | 0.782 | 0.763 | 0.814 | 0.703 | 0.616 | |||||||||||||||
... | ... | ... | ... | 5.59% | 4.97% | 4.45% | 4.47% | 4.56% |
Total Cash From Operations | EUR mil |
Total Cash From Investing | EUR mil |
Total Cash From Financing | EUR mil |
Net Change In Cash | EUR mil |
... | ... | ... | 1,587 | 1,532 | 1,403 | 1,767 | 1,934 | |||||||||||||||
... | ... | ... | -526 | -563 | -702 | -859 | -931 | |||||||||||||||
... | ... | ... | ... | -893 | -995 | -672 | -926 | -801 | ||||||||||||||
... | ... | ... | ... | 169 | -26.2 | 28.7 | -18.1 | 203 |
... | ... | ... | 21,172 | 21,497 | 22,724 | 25,837 | 26,015 | |||||||||||||||
... | ... | ... | 307 | 304 | 303 | 305 | 306 | |||||||||||||||
... | ... | ... | 52.3 | 51.2 | 62.0 | 77.8 | 80.4 | |||||||||||||||
... | ... | ... | 3.01 | 2.75 | 2.60 | 3.04 | 3.67 | |||||||||||||||
... | ... | ... | 24.0 | 24.1 | 29.6 | 34.8 | 39.3 | |||||||||||||||
... | ... | ... | 0.751 | 0.770 | 0.781 | 0.801 | 0.958 | |||||||||||||||
... | ... | ... | 17.4 | 18.7 | 23.8 | 25.6 | 21.9 | |||||||||||||||
... | ... | ... | 2.18 | 2.12 | 2.09 | 2.24 | 2.05 | |||||||||||||||
... | ... | ... | 1.44% | 1.50% | 1.26% | 1.03% | 1.19% | |||||||||||||||
... | ... | ... | ... | 19.1% | -8.78% | -5.21% | 17.0% | 20.6% | ||||||||||||||
... | ... | ... | ... | 12.0% | 0.453% | 22.7% | 17.4% | 13.0% |
income statement | Unit |
1996 | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 |
Sales | EUR mil |
Cost of Goods & Services | EUR mil |
Gross Profit | EUR mil |
Other Cost | EUR mil |
EBITDA | EUR mil |
Depreciation | EUR mil |
EBIT | EUR mil |
Financing Cost | EUR mil |
Extraordinary Cost | EUR mil |
Pre-Tax Profit | EUR mil |
Tax | EUR mil |
Minorities | EUR mil |
Net Profit | EUR mil |
Dividends | EUR mil |
... | ... | ... | 10,739 | 11,003 | 11,937 | 15,089 | 16,191 | |||||||||||||||
... | ... | ... | 7,159 | 7,434 | 8,170 | 10,283 | 10,966 | |||||||||||||||
... | ... | ... | 3,581 | 3,569 | 3,767 | 4,806 | 5,225 | |||||||||||||||
... | ... | ... | 1,408 | 1,406 | 1,538 | 2,037 | 2,200 | |||||||||||||||
... | ... | ... | 2,173 | 2,163 | 2,229 | 2,769 | 3,025 | |||||||||||||||
... | ... | ... | 469 | 488 | 527 | 647 | 701 | |||||||||||||||
... | ... | ... | 1,704 | 1,674 | 1,702 | 2,122 | 2,323 | |||||||||||||||
... | ... | ... | 332 | 308 | 310 | 353 | 367 | |||||||||||||||
... | ... | ... | -132 | -24.8 | 2.00 | 24.5 | -60.8 | |||||||||||||||
... | ... | ... | 1,504 | 1,392 | 1,390 | 1,745 | 2,018 | |||||||||||||||
... | ... | ... | 471 | 446 | 440 | 561 | 618 | |||||||||||||||
... | ... | ... | 109 | 110 | 162 | 256 | 276 | |||||||||||||||
... | ... | ... | 924 | 836 | 788 | 928 | 1,124 | |||||||||||||||
... | ... | ... | 229 | 234 | 236 | 244 | 293 |
Total Revenue Growth | % |
Operating Cost Growth | % |
EBITDA Growth | % |
EBIT Growth | % |
Pre-Tax Profit Growth | % |
Net Profit Growth | % |
... | ... | ... | ... | 18.8% | 2.46% | 8.49% | 26.4% | 7.30% | ||||||||||||||
... | ... | ... | ... | 25.9% | -0.137% | 9.36% | 32.5% | 7.97% | ||||||||||||||
... | ... | ... | ... | 16.4% | -0.465% | 3.08% | 24.2% | 9.25% | ||||||||||||||
... | ... | ... | ... | 16.2% | -1.71% | 1.64% | 24.7% | 9.49% | ||||||||||||||
... | ... | ... | ... | ... | 17.6% | -7.45% | -0.116% | 25.5% | 15.6% | |||||||||||||
... | ... | ... | ... | 19.9% | -9.49% | -5.72% | 17.8% | 21.1% |
ROE | % |
ROCE | % |
Gross Margin | % |
EBITDA Margin | % |
EBIT Margin | % |
Net Margin | % |
Payout Ratio | % |
Cost of Financing | % |
Net Debt/EBITDA |
... | ... | ... | 13.3% | 11.4% | 9.66% | 9.48% | 9.93% | |||||||||||||||
... | ... | ... | ... | 7.00% | 5.99% | 5.04% | 5.04% | 5.55% | ||||||||||||||
... | ... | ... | 33.3% | 32.4% | 31.6% | 31.9% | 32.3% | |||||||||||||||
... | ... | ... | 20.2% | 19.7% | 18.7% | 18.3% | 18.7% | |||||||||||||||
... | ... | ... | 15.9% | 15.2% | 14.3% | 14.1% | 14.4% | |||||||||||||||
... | ... | ... | 8.60% | 7.60% | 6.60% | 6.15% | 6.94% | |||||||||||||||
... | ... | ... | 24.8% | 28.0% | 30.0% | 26.3% | 26.1% | |||||||||||||||
... | ... | ... | ... | 5.59% | 4.97% | 4.45% | 4.47% | 4.56% | ||||||||||||||
... | ... | ... | 2.65 | 2.59 | 3.27 | 2.69 | 2.45 |
balance sheet | Unit |
1996 | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 |
Non-Current Assets | EUR mil |
Property, Plant & Equipment | EUR mil |
Intangible Assets | EUR mil |
Goodwill | EUR mil |
Current Assets | EUR mil |
Inventories | EUR mil |
Receivables | EUR mil |
Cash & Cash Equivalents | EUR mil |
Total Assets | EUR mil |
Shareholders' Equity | EUR mil |
Of Which Minority Interest | EUR mil |
Liabilities | EUR mil |
Non-Current Liabilities | EUR mil |
Long-Term Debt | EUR mil |
Deferred Tax Liabilities | EUR mil |
Current Liabilities | EUR mil |
Short-Term Debt | EUR mil |
Trade Payables | EUR mil |
Equity And Liabilities | EUR mil |
... | ... | ... | 12,274 | 12,208 | 15,424 | 17,115 | 18,602 | |||||||||||||||
... | ... | ... | 2,228 | 2,242 | 2,719 | 3,153 | 3,578 | |||||||||||||||
... | ... | ... | 9,193 | 9,004 | 11,530 | 12,758 | 13,761 | |||||||||||||||
... | ... | ... | 8,655 | 8,455 | 10,812 | 11,994 | 12,958 | |||||||||||||||
... | ... | ... | 4,643 | 4,559 | 5,552 | 6,229 | 6,935 | |||||||||||||||
... | ... | ... | 786 | 796 | 922 | 1,234 | 1,337 | |||||||||||||||
... | ... | ... | 2,288 | 2,203 | 2,648 | 3,023 | 3,341 | |||||||||||||||
... | ... | ... | 521 | 495 | 524 | 506 | 708 | |||||||||||||||
... | ... | ... | 16,918 | 16,767 | 20,976 | 23,344 | 25,537 | |||||||||||||||
... | ... | ... | 7,373 | 7,349 | 8,969 | 10,606 | 12,040 | |||||||||||||||
... | ... | ... | ... | 597 | 652 | 1,165 | 1,507 | 1,791 | ||||||||||||||
... | ... | ... | 9,544 | 9,418 | 12,007 | 12,738 | 13,498 | |||||||||||||||
... | ... | ... | 7,142 | 6,841 | 9,133 | 8,919 | 8,721 | |||||||||||||||
... | ... | ... | 5,942 | 5,618 | 7,450 | 7,228 | 6,829 | |||||||||||||||
... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | 503 | 539 | 665 | 575 | 637 | ||||||
... | ... | ... | 2,402 | 2,577 | 2,874 | 3,819 | 4,776 | |||||||||||||||
... | ... | ... | 346 | 486 | 373 | 729 | 1,298 | |||||||||||||||
... | ... | ... | 1,340 | 1,309 | 1,600 | 1,935 | 2,206 | |||||||||||||||
... | ... | ... | 16,918 | 16,767 | 20,976 | 23,344 | 25,537 |
... | ... | ... | ... | 12.2% | -0.890% | 25.1% | 11.3% | 9.40% | ||||||||||||||
... | ... | ... | ... | 12.8% | -0.332% | 22.1% | 18.2% | 13.5% | ||||||||||||||
... | ... | ... | ... | 10.7% | -2.73% | 30.1% | 2.09% | -0.440% | ||||||||||||||
... | ... | ... | ... | 13.0% | -2.92% | 28.2% | 1.71% | 2.14% |
Total Debt | EUR mil |
Net Debt | EUR mil |
Working Capital | EUR mil |
Capital Employed | EUR mil |
Net Debt/Equity | |
Cost of Financing | % |
... | ... | ... | 6,288 | 6,104 | 7,823 | 7,957 | 8,127 | |||||||||||||||
... | ... | ... | 5,767 | 5,609 | 7,299 | 7,451 | 7,419 | |||||||||||||||
... | ... | ... | 1,734 | 1,689 | 1,970 | 2,323 | 2,473 | |||||||||||||||
... | ... | ... | 14,008 | 13,897 | 17,393 | 19,437 | 21,075 | |||||||||||||||
... | ... | ... | 0.782 | 0.763 | 0.814 | 0.703 | 0.616 | |||||||||||||||
... | ... | ... | ... | 5.59% | 4.97% | 4.45% | 4.47% | 4.56% |
cash flow | Unit |
1996 | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 |
Net Profit | EUR mil |
Depreciation | EUR mil |
Non-Cash Items | EUR mil |
Change in Working Capital | EUR mil |
Total Cash From Operations | EUR mil |
Capital Expenditures | EUR mil |
Other Investments | EUR mil |
Total Cash From Investing | EUR mil |
Dividends Paid | EUR mil |
Issuance Of Shares | EUR mil |
Issuance Of Debt | EUR mil |
Total Cash From Financing | EUR mil |
Net Change In Cash | EUR mil |
... | ... | ... | 924 | 836 | 788 | 928 | 1,124 | |||||||||||||||
... | ... | ... | 469 | 488 | 527 | 647 | 701 | |||||||||||||||
... | ... | ... | ... | 214 | 163 | 369 | 545 | 259 | ||||||||||||||
... | ... | ... | ... | -19.6 | 45.1 | -281 | -353 | -150 | ||||||||||||||
... | ... | ... | 1,587 | 1,532 | 1,403 | 1,767 | 1,934 | |||||||||||||||
... | ... | ... | -526 | -563 | -702 | -859 | -931 | |||||||||||||||
... | ... | ... | 0 | 0 | 0 | 0 | 0 | |||||||||||||||
... | ... | ... | -526 | -563 | -702 | -859 | -931 | |||||||||||||||
... | ... | ... | ... | -209 | -229 | -234 | -236 | -244 | ||||||||||||||
... | ... | ... | ... | -296 | -1,089 | 598 | 472 | 66.1 | ||||||||||||||
... | ... | ... | ... | 724 | -184 | 1,719 | 134 | 170 | ||||||||||||||
... | ... | ... | ... | -893 | -995 | -672 | -926 | -801 | ||||||||||||||
... | ... | ... | ... | 169 | -26.2 | 28.7 | -18.1 | 203 |
Days Sales Outstanding | days |
Days Sales Of Inventory | days |
Days Payable Outstanding | days |
Cash Conversion Cycle | days |
Cash Earnings | EUR mil |
Cash Earnings Per Share | EUR |
Price/Cash Earnings (P/CE) | |
Free Cash Flow | EUR mil |
Free Cash Flow Yield | % |
... | ... | ... | 77.8 | 73.1 | 81.0 | 73.1 | 75.3 | |||||||||||||||
... | ... | ... | 40.1 | 39.1 | 41.2 | 43.8 | 44.5 | |||||||||||||||
... | ... | ... | 68.3 | 64.3 | 71.5 | 68.7 | 73.4 | |||||||||||||||
... | ... | ... | 49.5 | 47.8 | 50.7 | 48.3 | 46.4 | |||||||||||||||
... | ... | ... | 1,393 | 1,324 | 1,315 | 1,575 | 1,825 | |||||||||||||||
... | ... | ... | 4.54 | 4.35 | 4.34 | 5.16 | 5.96 | |||||||||||||||
... | ... | ... | 11.5 | 11.8 | 14.3 | 15.1 | 13.5 | |||||||||||||||
... | ... | ... | 1,061 | 969 | 701 | 908 | 1,003 | |||||||||||||||
... | ... | ... | 6.44% | 5.99% | 3.98% | 4.03% | 4.13% |
other data | Unit |
1996 | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 |
ROA | % |
Gross Margin | % |
Effective Tax Rate | % |
Enterprise Value (EV) | USD mil |
EV/EBITDA | |
EV/Capital Employed | |
EV/Sales | |
EV/EBIT |
... | ... | ... | 5.77% | 4.96% | 4.18% | 4.19% | 4.60% | |||||||||||||||
... | ... | ... | 33.3% | 32.4% | 31.6% | 31.9% | 32.3% | |||||||||||||||
... | ... | ... | ... | 31.3% | 32.0% | 31.7% | 32.1% | 30.6% | ||||||||||||||
... | ... | ... | 28,782 | 29,229 | 31,559 | 33,949 | 33,849 | |||||||||||||||
... | ... | ... | 10.3 | 10.2 | 11.0 | 10.7 | 10.4 | |||||||||||||||
... | ... | ... | 1.56 | 1.53 | 1.50 | 1.60 | 1.52 | |||||||||||||||
... | ... | ... | 2.09 | 2.00 | 2.05 | 1.96 | 1.95 | |||||||||||||||
... | ... | ... | 13.2 | 13.2 | 14.4 | 14.0 | 13.6 |
This Annual Statistical Dossier offers a summary of Fresenius Medical Care's performance between 1996 and 2018 on an annual basis. The report can be downloaded as an Excel file.
You will find here the key numbers from the company's balance sheet, income statement, cash flow and the main ratios related to the firm's business.
If you are only
Read more »This Annual Statistical Dossier offers a summary of Fresenius Medical Care's performance between 1996 and 2018 on an annual basis. The report can be downloaded as an Excel file.
You will find here the key numbers from the company's balance sheet, income statement, cash flow and the main ratios related to the firm's business.
If you are only interested in particular areas of the company's business, you can find and download specific indicators from the company's Corporate Profile, or specific charts from the company's Chart Section.
If you are interested in the company’s quarterly figures, please refer to the company’s Quarterly Statistical Dossier.
Fresenius Medical Care made a net profit of EUR 1,982 mil under revenues of EUR 16,547 mil in 2018, up 54.9% and -6.95%, respectively, when compared to the last year. This translates into a net margin of 12.0%.
Historically,
Read more »Fresenius Medical Care made a net profit of EUR 1,982 mil under revenues of EUR 16,547 mil in 2018, up 54.9% and -6.95%, respectively, when compared to the last year. This translates into a net margin of 12.0%.
Historically, the firm’s net profit reached an all time high of EUR 1,982 mil in 2018 and an all time low of EUR -234 mil in 1999. Since 2013, the firm's net profit has increased 137% or 18.8% a year on average.
On the operating level, EBITDA reached EUR 2,880 mil, up -1.05% when compared to the previous year. Over the last five years, company's EBITDA has grown 5.90% a year on average.
You can see all the company’s data at Fresenius Medical Care Profile, or you can download a report on the company in the report section.
Fresenius Medical Care's net debt reached EUR 5,401 mil and accounted for 0.419 of equity at the end of 2018. The ratio is down 29.9% when compared to the previous year.
Historically, the firm’s net debt to equity reached an
Read more »Fresenius Medical Care's net debt reached EUR 5,401 mil and accounted for 0.419 of equity at the end of 2018. The ratio is down 29.9% when compared to the previous year.
Historically, the firm’s net debt to equity reached an all time high of 1.11 in 1999 and an all time low of 0.419 in 2018.
When compared to EBITDA, net debt amounted to 1.88x at the end of the year. The ratio reached an all time high of 3.27 in 2014 and an all time low of 1.86 in 2005.
You can see all the company’s data at Fresenius Medical Care Profile, or you can download a report on the company in the report section.
Fresenius Medical Care made a net profit of EUR 1,982 mil in 2018, up 54.9% when compared to the previous year. Historically, company's net profit reached an all time high of EUR 1,982 mil in 2018 and an all time low of EUR 70.8 mil in 2001.
Read more »Fresenius Medical Care made a net profit of EUR 1,982 mil in 2018, up 54.9% when compared to the previous year. Historically, company's net profit reached an all time high of EUR 1,982 mil in 2018 and an all time low of EUR 70.8 mil in 2001.
This implies return on equity of 16.7% and return on invested capital of 9.43% in 2018. That is compared to 11.4% and 6.24% average seen in the last five years.
Since 2013, net profit of the firm increased by 57.5% or 9.51% a year on average.
You can see all the company’s data at Fresenius Medical Care Profile, or you can download a report on the company in the report section.
Fresenius Medical Care's total assets reached EUR 26,242 mil at the end of 2018, up 8.14% when compared to the previous year.
Current assets amounted to EUR 7,847 mil, or 29.9% of total assets while cash reached EUR 2,146 mil at the end of 2018.
Read more »Fresenius Medical Care's total assets reached EUR 26,242 mil at the end of 2018, up 8.14% when compared to the previous year.
Current assets amounted to EUR 7,847 mil, or 29.9% of total assets while cash reached EUR 2,146 mil at the end of 2018.
On the other hand, total debt reached EUR 7,546 mil at the year-end, or 29.9% of total assets while firm's equity amounted to EUR 12,902 mil. As a result, net debt reached EUR 5,401 mil at the end of 2018 and accounted for 41.9% of equity.
You can see all the company’s data at Fresenius Medical Care Profile, or you can download a report on the company in the report section.